ported the enhancement of reovirus infectivity by treatment of infectious culture fluids with heat in the presence of 2 M MgC12. Spendlove and Schaffer (10) found the infectivity of some reovirus culture fluids to be enhanced by certain proteolytic enzymes, and that this was due to alteration of a proteinaceous material associated with the virus particles.
Although there have been several studies on the growth of infectious reovirus in mammalian cells (2, (4) (5) (6) 9) , the development of enzymatically enhanceable virus, i.e., potentially infectious virus (PIV), has not been investigated. Consequently, a study of the development and release of infectious virus (IV) and PIV was undertaken, and results are presented in this report.
MATERIALS AND METHODS
Most materials and methods used in this investigation have been described in detail previously (9) .
Virus. Type 1 reovirus (Lang strain) was obtained from Herbert Wenner as infectious HeLa cell culture fluid.
Cells. The FL line of human amnion cells was obtained from the Naval Biological Laboratory, Berkeley, Calif., and was passaged in a medium composed of lactalbumin hydrolysate-yeast extract, Earle's salt solution, and 10% human serum (9) .
Experimental procedure. Cultures of FL cells in 3-oz prescription bottles were infected with a multiplicity of 50 to 100 infectious particles per cell with chymotrypsin-treated preparations of Lang strain of 1 Present address: Department of Bacteriology and Public Health, Utah State University, Logan. type 1 reovirus. After a 2-hr adsorption period, the cell sheets were washed twice, 4 ml of serum-free medium was added per bottle, and the cultures were incubated at 35 C. At intervals after infection, the fluids from two to five cultures were centrifuged; the cells were suspended in serum-free medium, and were frozen and thawed six times to release cell-associated virus. Samples of infected cells and extracellular fluids were assayed for infectivity by use of an immunofluorescent-cell counting technique (7) before and after chymotrypsin treatment.
Enzyme treatmenit. Enzymatic enhancement of reovirus infectivity has been described (10) . Culture fluids containing virus were incubated for 1 hr at 37 C in the presence of 20 ,g/ml of chymotrypsin.
REsULTS
Cultures sampled at various intervals after infection were assayed before and after chymotrypsin treatment to determine the titers of cellfree and cell-associated IV and PIV (Fig. 1) . Infectivity assays of untreated virus suspensions enumerated IV, and assays of chymotrypsintreated suspensions minus IV gave PIV counts.
The growth curve in Fig. 1 is representative of the five experiments performed in this investigation. The total maximal yield of cell-free and cell-associated PIV was more than 10 times higher than that of the IV. Although earlier reports (2, (4) (5) (6) 9) showed most of the IV to be retained by infected cells, most of the PIV in this study appeared to be selectively released from the cells.
The cell-free PIV appeared to acquire resistance to activation by chymotrypsin in the late stages of growth; i.e., the titer of the cell-free PIV dropped rapidly soon The infectivity titers of all samples were determined; the untreated virus was assayed before and after treatment with chymotrypsin (Table 1) . Averaging the results of the four experiments showed that the infectivity of the crude (untreated) virus dropped 77 % when the sample was incubated without prior enzyme treatment. The infectivity of those preparations which were enzyme-treated before incubation dropped an average of 93%. The titers of untreated virus which was treated with enzyme after incubation dropped 49%, as compared with enzyme-treated virus assayed before incubation. Thus, approximately half of the loss of infectivity was attributable to thermal inactivation.
An earlier study (10) showed enzyme-treated virus to be more thermolabile than untreated virus. This observation was confirmed in the experiments presented in Table 1 . Release of proteolytic enzymes into the culture medium could result in a conversion of PIV to IV with greater thermal inactivation; such loss could conceivably be kept to low levels by periodic changes of the culture medium. When the medium on infected cultures was changed, there was an increase in the total yield of cell-free, enzymatically enhanceable virus. Figure 2 shows the results obtained with cell-free, chymotrypsin-treated virus from an experiment in which the medium on different infected cultures was changed from zero to three times. There was a typical loss of enhanceability in the unchanged control (bottom curve). The total yield of virus enhanceable by enzyme in- 
DIscussIoN
The characteristics of reovirus growth which have been reported previously (2, (4) (5) (6) 9) are: (i) a latent period of 6 to 9 hr; (ii) a slow intracytoplasmic development of infectious virus (the maximal concentration of cell-associated virus appeared between 15 and 54 hr in the various studies); (iii) a limited release of infectious type 1 and 3 virus (only 7 to 22% of the total infectious virus was released), and a 55% release of reovirus type 2 from infected cells (4); and (iv) a total yield of infectious virus particles between 225 and 2,600 per cell.
In the above studies of reovirus growth, no information was obtained on the development of PIV. When total virus (IV and PIV) development and release are considered, the growth of the Lang strain in, and release from, FL cells differs Isaacs (3) showed, by use of six examples, that ribonucleic acid (RNA) viruses in general have a shorter lag period and a faster rate of increase than deoxyribonucleic acid (DNA) viruses. Gomatos et al. (2) added several other examples to Isaacs' list, and noted that reovirus is an unusual RNA virus in that its multiplication is relatively slow. Since the reoviruses contain doublestranded RNA, it would not be surprising to find their growth to be slow and more like that of double-stranded DNA viruses. However, the production of IV plus PIV in cells infected with the Lang strain of reovirus is comparable with the rate of growth of most other RNA viruses.
Isaacs (3) pointed out that a rate of increase of infectivity of the order of about 1 log1o per hour has been reported for poliovirus, Western equine encephalitis virus, influenza virus, and Newcastle disease virus. The reported yields of infective doses per cell with the respective viruses were 100, 200 to 1,000, 650, and 1,000. These reports were of early studies, and the yields are certainly not maximal for these viruses; however, the figures can be used in comparison to show that the latent period for reovirus is not long, the rate of development is not slow, and the final yield of virus is not low.
In the present studies, a short latent period was indicated. Although early samples were not taken, it seems unlikely that the latent period extended for 6 hr, the shortest latent period reported earlier, because more than 2,400 PIV particles were produced by 8 The maximal reovirus accumulation (cell-free and cell-associated IV plus PIV) exceeded 10,000 infectious units per cell at 32 hr postinoculation, although the maximal concentration of cellassociated PIV was reached relatively late in the infection (between 16 and 32 hr postinfection); this was not because of a slow rate of PIV synthesis, but was probably because of limited host-cell damage with continued virus synthesis. An accumulated yield of over 18,000 IV plus PIV particles per cell was obtained in one experiment, in which the cell density was reduced and the medium on the infected cells was replaced several times.
An interesting aspect of virus release was that PIV appeared to be selectively released and the IV selectively retained, or that both were released but the IV was thermally inactivated at a much more rapid rate than the PIV. This was evident in three observations: (i) the peak concentration of cell-associated PIV always appeared at an earlier time than that of the IV, i.e., the cellassociated PIV appeared to be released and did not continue to accumulate; (ii) as the rate of increase of the cell-associated PIV began to decline, there was a corresponding increase in the cell-free PIV (this was not as evident with the IV); and (iii) the maximal concentration of cellfree PIV was always equal to, or greater than, that of the cell-associated PIV, whereas the maximal concentration of cell-free IV was always much less than the maximal cell-associated IV.
A better explanation of the development and release of PIV awaits the elucidation of the relationship of PIV to IV. A previous study (10) showed that the enzymatic enhancement of reovirus infectivity was due to proteolytic action upon a virus-associated substrate. It was not determined whether the substrate was a bound inhibitor or some portion of the virus coat. The enhancement did not appear to be due to disaggregation of clumps of virus, since hemagglutinating activity of the virus was not enhanced.
The reoviruses have been shown to associate themselves with the spindles of the mitotic apparatus (1, 7, 8) ; however, it is unlikely that the inhibition is due to attachment of virus to spindle tubules. This would require a selective release of spindle tubule material with accompanying virus from the cell and retention of virus that was not associated with the spindle, or association of virus with the spindle would have to prevent the virus from becoming inhibited and also from being released.
In this investigation, the titer of the cell-free virus decreased in the later stages of the growth period. A logical explanation would be that cellular proteolytic enzymes were acting on the released virus, making it more susceptible to thermal inactivation. Whatever the mechanism, the knowledge that loss of enhanceability occurs can be applied in the production of high-titered virus stocks. Nonenhanceability can be minimized by periodic changes of the medium on infected cells, and also by maintaining a relatively low cell density in the infected cultures.
The early studies on reovirus growth (2, (4) (5) (6) 9) 
